{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T09:09:54Z","timestamp":1697447394292},"reference-count":24,"publisher":"Baishideng Publishing Group Inc.","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.4535","type":"journal-article","created":{"date-parts":[[2008,8,7]],"date-time":"2008-08-07T06:42:58Z","timestamp":1218091378000},"page":"4535","source":"Crossref","is-referenced-by-count":12,"title":["Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention"],"prefix":"10.3748","volume":"14","author":[{"given":"Guo-Shuang","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin CY","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry HX","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-You","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiu Kum","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Cheng","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-1528, 2 p following 1528.","DOI":"10.1056\/NEJM200011233432103"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med 2006;119:255-266.","DOI":"10.1016\/j.amjmed.2005.09.054"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Gasparini G, Longo R, Sarmiento R, Morabito A. Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 2003;4:605-615.","DOI":"10.1016\/S1470-2045(03)01220-8"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-1952.","DOI":"10.1056\/NEJM200006293422603"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 2006;6:27.","DOI":"10.1186\/1471-2407-6-27"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Langman MJ, Jensen DM, Watson DJ, Harper SE, Zhao PL, Quan H, Bolognese JA, Simon TJ. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999;282:1929-1933.","DOI":"10.1001\/jama.282.20.1929"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092-1102.","DOI":"10.1056\/NEJMoa050493"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006;355:873-884.","DOI":"10.1056\/NEJMoa061355"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Psaty BM, Potter JD. Risks and benefits of celecoxib to prevent recurrent adenomas. N Engl J Med 2006;355:950-952.","DOI":"10.1056\/NEJMe068158"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Graham DJ. COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA 2006;296:1653-1656.","DOI":"10.1001\/jama.296.13.jed60058"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Okie S. Raising the safety bar--the FDA's coxib meeting. N Engl J Med 2005;352:1283-1285.","DOI":"10.1056\/NEJMp058055"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"You WC, Li JY, Blot WJ, Chang YS, Jin ML, Gail MH, Zhang L, Liu WD, Ma JL, Hu YR. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999;83:615-619.","DOI":"10.1002\/(SICI)1097-0215(19991126)83:5<615::AID-IJC8>3.0.CO;2-L"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106.","DOI":"10.1136\/bmj.308.6921.81"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-1255.","DOI":"10.1001\/jama.284.10.1247"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 1999;354:2106-2111.","DOI":"10.1016\/S0140-6736(99)02332-6"},{"key":"ref16","unstructured":"Brinkmann G, Burkhart C, Clausen M, Henze E. [The effect of Belzer and Bretschneider cardioplegia solutions on myocardial energy metabolism. A study with 31phosphorus magnetic resonance spectroscopy in an animal model]. Z Kardiol 1992;81:339-344."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Pharmacoepidemiol Drug Saf 2007;16:366-376.","DOI":"10.1002\/pds.1299"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Kasliwal R, Layton D, Harris S, Wilton L, Shakir SA. A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data. Drug Saf 2005;28:803-816.","DOI":"10.2165\/00002018-200528090-00005"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ 2002;325:619.","DOI":"10.1136\/bmj.325.7365.619"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Arber N, Eagle CJ, Spicak J, Racz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006;355:885-895.","DOI":"10.1056\/NEJMoa061652"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071-1080.","DOI":"10.1056\/NEJMoa050405"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Fitzgerald GA. Coxibs and cardiovascular disease. N Engl J Med 2004;351:1709-1711.","DOI":"10.1056\/NEJMp048288"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Hawkey CJ. COX-2 inhibitors. Lancet 1999;353:307-314.","DOI":"10.1016\/S0140-6736(98)12154-2"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Antman EM, DeMets D, Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation 2005;112:759-770.","DOI":"10.1161\/CIRCULATIONAHA.105.568451"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i28\/4535.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T01:13:35Z","timestamp":1557710015000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i28\/4535.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":24,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.4535","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}